Tag: Neurological side effects

While Xcopri (cenobamate) can significantly reduce seizures in adults with focal epilepsy, a pooled analysis of clinical trial data showed that memory impairment was a treatment-emergent adverse event in a small percentage of patients, with the incidence rising with higher doses. Does Xcopri affect memory is a key question for many patients considering this medication.

While Eliquis is highly effective for preventing blood clots, mental confusion is a rare but potentially serious side effect that has been reported. The most critical concern is that confusion can be a sign of a life-threatening bleeding event, such as a hemorrhage in the brain.

Confusion is listed as a rare side effect of apixaban. While uncommon, reports confirm that **can apixaban make you confused**, but this symptom sometimes indicates a serious underlying complication such as intracranial bleeding, which necessitates immediate medical attention.

While tamoxifen is a life-saving medication for many individuals with estrogen receptor-positive breast cancer, a significant subset of users reports experiencing neurological side effects. Concerns over these adverse effects, which range from cognitive issues to mood disturbances, are growing as patients are prescribed tamoxifen for increasingly longer durations. This article explores what are the neurological side effects of tamoxifen, including its impact on cognitive function, mood, and other serious neurological risks.

In 2020, prochlorperazine was prescribed over 600,000 times in the United States [1.5.3]. So, what does prochlorperazine do to the brain? This medication primarily acts by blocking dopamine D2 receptors in key areas, leading to its anti-nausea and antipsychotic effects [1.2.1, 1.2.3].

According to clinical trial data, headaches were reported by 14% of adult patients taking Wegovy, suggesting that a “weird” sensation in the head, while not universal, is a recognized side effect. Several factors contribute to these feelings, from simple dehydration to more complex metabolic adjustments.

In a documented case involving a head-injured patient, the intravenous administration of metoclopramide was linked to a significant, acute increase in intracranial pressure (ICP). This rare but serious complication prompts a closer look at whether and how metoclopramide can increase intracranial pressure and its broader spectrum of neurological side effects.

Reports indicate that confusion can occur while taking Jakafi (ruxolitinib), and it can sometimes be a sign of a serious underlying condition. It is crucial for patients and caregivers to be aware of this potential adverse effect and know when to seek immediate medical attention.

In clinical trials for myelofibrosis, dizziness and headache were among the most common adverse events reported by patients taking ruxolitinib. Beyond these milder issues, it is crucial to understand what are the neurological side effects of ruxolitinib, as some can be more serious and require immediate medical attention.

Based on analysis of FDA adverse event data, Paxlovid has been associated with a higher number of neurologic-related adverse events compared to other COVID-19 medications used to treat the virus. So, **does Paxlovid affect the nervous system**? The answer is yes, though primarily with mild and often transient symptoms, with the potential for more significant effects due to drug interactions.